NCT00332397View on ClinicalTrials.gov

The Efficacy of Three Different Limus Agent-Eluting Stents to Prevent Restenosis

PHASE4CompletedINTERVENTIONAL
Enrollment

1,007

Participants

Timeline

Start Date

March 31, 2006

Study Completion Date

July 31, 2007

Conditions
Coronary Disease
Interventions
DEVICE

Rapamycin-eluting Stent

due to randomization, Cypher stent will be implanted

DEVICE

Zotarolimus-eluting Stent

due to randomization, Endeavor stent will be implanted

DEVICE

Rapamycin-eluting Stent

due to randomization, rapamycin-eluting stent will be implanted

Trial Locations (2)

80636

Deutsches Herzzentrum Muenchen, Munich

81675

First Medizinische Klinik, Klinikum rechts der Isar, Munich

All Listed Sponsors
lead

Deutsches Herzzentrum Muenchen

OTHER

NCT00332397 - The Efficacy of Three Different Limus Agent-Eluting Stents to Prevent Restenosis | Biotech Hunter | Biotech Hunter